[go: up one dir, main page]

NO20062699L - Smelteblandingsdispergeringer - Google Patents

Smelteblandingsdispergeringer

Info

Publication number
NO20062699L
NO20062699L NO20062699A NO20062699A NO20062699L NO 20062699 L NO20062699 L NO 20062699L NO 20062699 A NO20062699 A NO 20062699A NO 20062699 A NO20062699 A NO 20062699A NO 20062699 L NO20062699 L NO 20062699L
Authority
NO
Norway
Prior art keywords
smelteblandingsdispergeringer
bioavailability
dissolution
preparations
enhancing
Prior art date
Application number
NO20062699A
Other languages
English (en)
Inventor
Patrick S L Wong
Liang-Chang Dong
Dong Yan
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20062699L publication Critical patent/NO20062699L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives preparater eller blandinger, og metoder for å forsterke oppløsningen og biotilgjengeligheten for fordelaktige midler med lav vannoppløselighet.
NO20062699A 2003-11-13 2006-06-12 Smelteblandingsdispergeringer NO20062699L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51958103P 2003-11-13 2003-11-13
PCT/US2004/037615 WO2005048990A2 (en) 2003-11-13 2004-11-12 Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer

Publications (1)

Publication Number Publication Date
NO20062699L true NO20062699L (no) 2006-08-09

Family

ID=34619360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062699A NO20062699L (no) 2003-11-13 2006-06-12 Smelteblandingsdispergeringer

Country Status (13)

Country Link
US (1) US20050106242A1 (no)
EP (1) EP1682092A2 (no)
JP (1) JP2007511518A (no)
KR (1) KR20060123279A (no)
CN (1) CN1901885A (no)
AU (1) AU2004291080A1 (no)
CA (1) CA2545919A1 (no)
IL (1) IL175600A0 (no)
MX (1) MXPA06005461A (no)
NO (1) NO20062699L (no)
TW (1) TW200533374A (no)
WO (1) WO2005048990A2 (no)
ZA (1) ZA200604832B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027557A2 (en) * 2006-08-31 2008-03-06 Spherics, Inc. Topiramate compositions and methods of enhancing its bioavailability
EP1973528B1 (en) 2006-11-17 2012-11-07 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
WO2008070670A2 (en) * 2006-12-04 2008-06-12 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate
EP1972336A1 (en) * 2007-03-19 2008-09-24 LEK Pharmaceuticals D.D. Hot-melt micropellets
KR100958138B1 (ko) * 2008-01-10 2010-05-18 박성순 안정성이 우수한 초산메게스트롤 약학 조성물 및 그제조방법
WO2012021213A1 (en) * 2010-08-11 2012-02-16 Conocophillips Company-Ip Services Group Delayed gelling agents
WO2013037396A1 (en) * 2011-09-12 2013-03-21 Bioneer A/S Solution of polymer in api for a solid dosage form
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2017058869A1 (en) 2015-09-29 2017-04-06 Acorda Therapeutics, Inc. Sustained release compositions of 4-aminopyridine
US20190328667A1 (en) * 2016-11-10 2019-10-31 University Of Washington Drug-polymer particles with sustained release properties
KR101852718B1 (ko) * 2017-04-04 2018-05-18 주식회사 제네웰 외과수술 후 절개부위 통증 감소를 위한 키트
CN107198677B (zh) * 2017-05-25 2021-07-09 长春金赛药业有限责任公司 黄体酮混悬型长效注射剂及其制备方法和黄体酮混悬注射粉针

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
DE69811233T2 (de) * 1997-10-27 2003-11-20 Merck Patent Gmbh Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
IE980115A1 (en) * 1998-02-16 2000-02-09 Biovail Internat Ltd Solubilizing delivery systems and method of manufacture
CA2301042A1 (en) * 1998-06-11 1999-12-16 Em Industries, Inc. Micro-osmotic controlled drug delivery systems
TWI354568B (en) * 2000-09-20 2011-12-21 Jagotec Ag Insoluble drug particle compositions with improved
BR0210867A (pt) * 2001-07-06 2004-06-29 Lifecycle Pharma As Processo para a preparação de um material particulado, métodos para aglomeração controlada de um material sólido finamente disperso, para melhorar a biodisponibilidade de uma substância terapêutica e/ou profilaticamente ativa, e para melhorar a vida em prateleira de uma composição farmacêutica, material articulado, composição farmacêutica, uso de um veìculo, material particulado farmacêutico, e, uso de aluminossilicato de magnésio e/ou de aluminometassilicato de magnésio
US7163700B2 (en) * 2001-07-31 2007-01-16 Capricorn Pharma, Inc. Amorphous drug beads
SE0200895D0 (sv) * 2002-03-22 2002-03-22 Astrazeneca Ab New pharmaceutical composition

Also Published As

Publication number Publication date
IL175600A0 (en) 2006-09-05
AU2004291080A1 (en) 2005-06-02
KR20060123279A (ko) 2006-12-01
ZA200604832B (en) 2007-12-27
MXPA06005461A (es) 2006-12-15
CA2545919A1 (en) 2005-06-02
US20050106242A1 (en) 2005-05-19
JP2007511518A (ja) 2007-05-10
TW200533374A (en) 2005-10-16
WO2005048990A3 (en) 2005-10-13
EP1682092A2 (en) 2006-07-26
WO2005048990A2 (en) 2005-06-02
CN1901885A (zh) 2007-01-24

Similar Documents

Publication Publication Date Title
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
NO20062860L (no) Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet
ATE499109T1 (de) Zusammensetzung zur proteasomhemmung
TR200201187T2 (tr) Ters transkriptazın inhibitörleri olarak benzofenonlar
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
IS7520A (is) Pyrimidínonefnasambönd, samsetningar og aðferðir
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
DE60334536D1 (de) Furylverbindungen
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
NO20062699L (no) Smelteblandingsdispergeringer
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
DK1556371T3 (da) Benzimidazol-derivater og deres anvendelse som prodrugs for protonpumpe-inhibitorer
NO20032788L (no) Modafinil-forbindelse og cyklodekstrinblandinger
ATE247726T1 (de) Gezielte elektrochemische reduktion von halogenierten 4-amino-picolinsäuren
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
IS8219A (is) Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
ATE457977T1 (de) Biguanidderivate
NO20040210L (no) Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NL1024677A1 (nl) Therapeutische prolinederivaten.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application